AccurKardia, an innovator in ECG-based diagnostics technology, has announced that it has received Breakthrough Device ...

AccurKardia announced that it received FDA breakthrough device designation for its ECG-based, AI-powered hyperkalemia ...

LR-19155 is under clinical development by LG Chem and currently in Phase I for Non-Small Cell Lung Cancer. According to GlobalData, Phase I drugs for Non-Small Cell Lung Cancer have an 80% phase ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

FDA approves the first subcutaneous version of nivolumab, making PD-1 inhibitors available to new groups of patients.

Celebrity and fitness enthusiast Malaika Arora has shared a list of drinks she has while following the 16/8 intermittent ...

It's been another strong year for new research into the health benefits of natural foods and extracts, some of which have ...

INR:2987. how to bet online in usa 16 companies have passed the review for this product? China Resources Secco will "grab the market share" of original r ...

INR:2435. betfair live stream Shisiyao's Doxofylline Injection passed the consistency evaluation "Pharmaceutical Speed ​​Reading Club" Jiayi Pharmaceutica ...

INR:4592. football 2023 top scorer New drug for hyperkalemia in China! AstraZeneca's Ribezo® (sodium zirconium cyclosilicate) is launched Penguin Almond ...

EKBET Affiliate Annual review of the departures of well-known pharmaceutical executives AstraZeneca's new hyperkalemia drug Lokelma approved in Japan Un ...

INR:8345. kalyan satta Makoto Yamashita's team discovered the first super-basic alkylaluminum carbene analogue AstraZeneca's new hyperkalemia drug Lokelma approved i ...